Antitumor activity of NK cells

Immunologic Research

Volumn 36, Issue 1-3, 2006, Pages 13-25

  Yang, Q ^a   Goding, S R ^a   Hokland, M E ^b   Basse, P H ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Adoptive transfer; Antitumor activity; B16 melanoma; Biological response modifiers; Natural killer cells; Tissue distribution; Tumor infiltration

Indexed keywords

GANGLIOTETRAOSYLCERAMIDE; INTERLEUKIN 2; POLYINOSINIC POLYCYTIDYLIC ACID;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LUNG; MELANOMA B16; MELANOMA CELL; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR IMMUNITY;

EID: 33947104216     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:36:1:13     Document Type: Review

References (35)

1. Coca S, Perez-Piqueras J, Martinez D, et al: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997;79(12):2320-2328.
2. Ishigami S, Natsugoe S, Tokuda K, et al: Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 2000;88(3):577-583.
3. Villegas FR, Coca S, Villarrubia VG, et al: Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 2002;35(1):23-28.
4. Hsia JY, Chen JT, Chen CY, et al: Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma. Chang Gung Med J 2005;28(5):335-340.
5. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989;47:187-376.
6. Gorelik E, Bere WW, Herberman RB: Role of NK cells in the antimetastatic effect of anticoagulant drugs. Int J Cancer 1984;33(1):87-94.
7. Hanna N: Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev 1982;1(1):45-64.
8. Riccardi C, Puccetti P, Santoni A, Herberman RB: Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst 1979;63(4):1041-1045.
9. Talmadge JE, Adams J, Phillips H, et al: Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose. Cancer Res 1985;45(3):1066-1072.
10. Gorelik E, Fogel M, Feldman M, Segal S: Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. J Natl Cancer Inst 1979;63(6):1397-1404.
11. Wiltrout RH, Herberman RB, Zhang SR, et al: Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985;134(6):4267-4275.
12. Wiltrout RH, Mathieson BJ, Talmadge JE, et al: Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984;160(5):1431-1449.
13. Weiss L: Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int J Cancer 1980;25(3):385-392.
14. Basse P, Hokland P, Heron I, Hokland M: Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst 1988;80(9):657-665.
15. Basse PH, Hokland P, Gundersen HJ, Hokland M: Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. Apmis 1992;100(3):202-208.
16. Wiltrout RH, et al: Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J Immunol 1989;143(1):372-378.
17. Gunji Y, Vujanovic NL, Hiserodt JC, Herberman RB, Gorelik E: Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol 1989;142(5):1748-1754.
18. Vujanovic NL, Herberman RB, Maghazachi AA, Hiserodt JC: Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 1988;167(1):15-29.
19. Basse P, Herberman RB, Nannmark U, et al: Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med 1991;174(2):479-488.
20. Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH: Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J Natl Cancer Inst 1991;83(13):944-950.
21. Basse PH. Tissue distribution of natural killer cells and their role in clearance and metastasis of tumor cells. (PhD). University of Aarhus, DK; 1992.
22. Basse PH, Goldfarb RH, Herberman RB, Hokland ME: Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. In Vivo 1994;8(1):17-24.
23. Basse PH: Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer. APMIS Suppl 1995;55:1-28.
24. Yang Q, Hokland ME, Bryant JL, et al: Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. Int J Cancer 2003;105(4):512-519.
25. Hagenaars M, Ensink NG, Basse PH, et al: The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis 2000;18(2):189-196.
26. Kuppen PJ, van der Eb MM, Jonges LE, et al: Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem Cell Biol 2001;115(1):67-72.
27. Nannmark U, Basse P, Johansson BR, Kuppen P, Kjergaard J, Hokland M: Morphological studies of effector cell-microvessel interactions in adoptive immunotherapy in tumor-bearing animals. Nat Immun 1996;15(2-3):78-86.
28. Nannmark U, Hokland ME, Agger R, et al: Tumor blood supply and tumor localization by adoptively transferred IL- 2 activated natural killer cells. In Vivo 2000;14(5):651-658.
29. Nannmark U, Johansson BR, Bryant JL, et al: Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res 1995;55(20):4627-4632.
30. Yang Q, Goding S, Hagenaars M, et al: Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells. Cancer Immunol Immunother 2005:1-9.
31. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195(3):343-351.
32. Piccioli D, Sbrana S, Melandri E, Valiante NM: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195(3):335-341.
33. Zitvogel L: Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002;195(3):F9-14.
34. Kalinski P, Giermasz A, Nakamura Y, et al: Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol 2005;42(4):535-539.
35. Kalinski P, Mailliard RB, Giermasz A, et al: Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin Biol Ther 2005;5(10):1303-1315.